Outcomes of Traditional and Enhanced Gonorrhea Partner Services in the Strengthening the US Response to Resistant Gonorrhea Project, 2017 to 2019.


Journal

Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941

Informations de publication

Date de publication:
01 12 2021
Historique:
pubmed: 19 8 2021
medline: 15 12 2021
entrez: 18 8 2021
Statut: ppublish

Résumé

The Centers for Disease Control and Prevention implemented Strengthening the US Response to Resistant Gonorrhea (SURRG) to build local detection and response capacity and evaluate responses to antibiotic-resistant gonorrhea outbreaks, including partner services for gonorrhea. We evaluated outcomes of traditional partner services conducted under SURRG, which involved (1) counseling index patients and eliciting sexual partners; (2) interviewing, testing, and treating partners; and (3) providing partner services to partners newly diagnosed with gonorrhea. We also evaluated outcomes of enhanced partner services, which additionally involved interviewing and testing partners of persons who tested negative, and social contacts of index patients and partners. We analyzed partner services investigation data from 8 jurisdictions participating in SURRG from 2017 to 2019. We summed total index patients, partners from traditional partner services, and partners and contacts from enhanced partner services, and calculated partner services outcomes among partners and contacts. We also visualized sexual networks from partner services data. Of 1242 index patients identified, 506 named at least 1 sexual partner. Traditional partner services yielded 1088 sexual partners, and 105 were newly diagnosed with gonorrhea. Enhanced partner services yielded an additional 59 sexual partners and 52 social contacts. Of those partners and contacts, 3 were newly diagnosed with gonorrhea. Network visualization revealed sparse networks with few complex partnership clusters. Traditional partner services for gonorrhea may be useful for eliciting, notifying, and diagnosing partners of index patients in an outbreak setting. Enhanced partner services are unlikely to be effective for eliciting, notifying, and diagnosing a substantial number of additional people.

Identifiants

pubmed: 34407012
doi: 10.1097/OLQ.0000000000001527
pii: 00007435-202112002-00007
pmc: PMC8767793
mid: NIHMS1769102
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

S124-S130

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest and Sources of Funding: The Strengthening the US Response to Resistant Gonorrhea activities described in this article were supported by federal Antibiotic Resistance Initiative funding and administered through the US Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for the Prevention and Control of Infectious Diseases Cooperative Agreement (CK19-1904).

Références

St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC's treatment guidelines for gonococcal infection, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1911–1916.
Centers for Disease Control and Prevention (CDC). Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep 2008; 57(RR-9):1–83.
Rothenberg R. The transformation of partner notification. Clin Infect Dis 2002; 35(Suppl 2):S138–S145.
Hogben M, Collins D, Hoots B, et al. Partner services in sexually transmitted disease prevention programs: A review. Sex Transm Dis 2016; 43:S53–S62.
Schlanger K, Learner ER, Pham CD, et al. Strengthening the US Response to Resistant Gonorrhea: An overview of a multisite program to enhance local response capacity for antibiotic-resistant Neisseria gonorrhoeae . Sex Transm Dis 2021; 48(12S):S97–S103.
Samoff E, Cope AB, Maxwell J, et al. The number of interviews needed to yield new syphilis and human immunodeficiency virus cases among partners of people diagnosed with syphilis, North Carolina, 2015. Sex Transm Dis 2017; 44:451–456.
Campbell E, Boyles A, Shankar A, Kim J, Knyazev S, Switzer W. MicrobeTrace: Retooling molecular epidemiology for rapid public health response [Internet]. Available at: https://www.biorxiv.org/content/10.1101/2020.07.22.216275v1 . Accessed April 7, 2021.
Bradley H, Hogan V, Agnew-Brune C, et al. Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale. Ann Epidemiol 2019; 34:12–17.
Peters PJ, Pontones P, Hoover KW, et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. N Engl J Med 2016; 375:229–239.
Potterat JJ, Rothenberg RB, Muth SQ. Network structural dynamics and infectious disease propagation. Int J STD AIDS 1999; 10:182–185.
Juher D, Saldaña J, Kohn R, et al. Network-centric interventions to contain the syphilis epidemic in San Francisco. Sci Rep 2017; 7:6464.
Brewer DD. Case-finding effectiveness of partner notification and cluster investigation for sexually transmitted diseases/HIV. Sex Transm Dis 2005; 32:78–83.
Cope AB, Bernstein K, Matthias J, et al. Unnamed partners from syphilis partner services interviews, 7 jurisdictions. Sex Transm Dis 2020; 47:811–818.
Avoundjian T, Stewart J, Peyton D, et al. Integrating human immunodeficiency virus testing into syphilis partner services in Mississippi to improve human immunodeficiency virus case finding. Sex Transm Dis 2019; 46:240–245.
Nguyen TQ, Kohn RP, Ng RC, et al. Historical and current trends in the epidemiology of early syphilis in San Francisco, 1955 to 2016. Sex Transm Dis 2018; 45(9S supp 1):S55–S62.
Cope AB, Mobley VL, Samoff E, et al. The changing role of disease intervention specialists in modern public health programs. Public Health Rep 2019; 134:11–16.
Hogben M, Paffel J, Broussard D, et al. Syphilis partner notification with men who have sex with men: A review and commentary. Sex Transm Dis 2005; 32(Suppl 10):S43–S47.
Silverman RA, Katz DA, Levin C, et al. Sexually transmitted disease partner services costs, other resources, and strategies across jurisdictions to address unique epidemic characteristics and increased incidence. Sex Transm Dis 2019; 46:493–501.
Johnson BL, Tesoriero J, Feng W, et al. Cost analysis and performance assessment of partner services for human immunodeficiency virus and sexually transmitted diseases, New York State, 2014. Health Serv Res 2017; 52(Suppl 2):2331–2342.
Norkin SK, Benson S, Civitarese AM, et al. Inadequate engagement in HIV care among people with HIV newly diagnosed with a sexually transmitted disease: A multijurisdictional analysis. Sex Transm Dis 2021; 48:601–605.

Auteurs

Emily R Learner (ER)

From the Division of STD Prevention, National Center for HIV/AIDS, Hepatitis, STD Prevention and TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA.

Karen Schlanger (K)

From the Division of STD Prevention, National Center for HIV/AIDS, Hepatitis, STD Prevention and TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA.

Kerry Mauk (K)

From the Division of STD Prevention, National Center for HIV/AIDS, Hepatitis, STD Prevention and TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA.

Cau D Pham (CD)

From the Division of STD Prevention, National Center for HIV/AIDS, Hepatitis, STD Prevention and TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA.

Rachel Mukai (R)

Milwaukee Health Department, Milwaukee, WI.

Lacy Mulleavey (L)

Colorado Department of Public Health and Environment, Denver, CO.

Roxanne P Kerani (RP)

Division of Allergy and Infectious Disease, University of Washington/Public Health-Seattle & King County, Seattle, WA.

Terilyn Albano (T)

Hawaii Department of Health, Honolulu, HI.

Brandy Sessoms (B)

Guilford County Department of Health, Greensboro, NC.

Brian Toro (B)

New York City Department of Health and Mental Hygiene, New York City, NY.

Madeline Sankaran (M)

San Francisco Department of Public Health, San Francisco, CA.

Robert D Kirkcaldy (RD)

From the Division of STD Prevention, National Center for HIV/AIDS, Hepatitis, STD Prevention and TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH